INCY211119C00077500 Option on Incyte

INCY Stock  USD 53.43  0.42  0.78%   
Incyte's option chain provides insight into all available option contracts written on Incyte's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Incyte's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Incyte option contract.

In The Money vs. Out of Money Option Contracts on Incyte

Analyzing Incyte's in-the-money options over time can help investors to take a profitable long position in Incyte regardless of its overall volatility. This is especially true when Incyte's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Incyte's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Incyte's stock while costing only a fraction of its price.
Incyte's latest option contracts expiring on 2024-04-19 are carrying combined implied volatility of 54.02 with a put-to-call open interest ratio of 0.64 over 42 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2024-04-19. The current put volume is at 137, with calls trading at the volume of 10. This yields a 13.7 put-to-call volume ratio. The Incyte option chain provides detailed quote and price information for the current Incyte option contracts. It shows all of Incyte's listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2024-04-19 Option Contracts

Incyte option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Incyte's lending market. For example, when Incyte's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Incyte, he or she must hedge the risk by shorting Incyte stock over its option's life.
The chart above shows Incyte's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Incyte's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Incyte's option, there is no secondary market available for investors to trade.
Incyte's stock options are financial instruments that give investors the right to buy or sell shares of Incyte common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Incyte stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Incyte's stock price goes up or down, the stock options follow.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.
Please note that buying 'in-the-money' options on Incyte lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Incyte's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Incyte contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Incyte Stock moves the wrong way.
At this time, Incyte's Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 7.1 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 130.7 M in 2024.

Incyte In The Money Call Balance

When Incyte's strike price is surpassing the current stock price, the option contract against Incyte stock is said to be in the money. When it comes to buying Incyte's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Incyte are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Incyte Current Options Market Mood

Incyte's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Incyte Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Incyte's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Incyte's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Incyte's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Incyte contract

Base on the Rule 16, the options market is currently suggesting that Incyte will have an average daily up or down price movement of about 3.38% per day over the life of the 2024-04-19 option contract. With Incyte trading at USD 53.43, that is roughly USD 1.8. If you think that the market is fully incorporating Incyte's daily price movement you should consider buying Incyte options at the current volatility level of 54.02%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Incyte options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Incyte calls. Remember, the seller must deliver Incyte stock to the call owner when a call is exercised.

Incyte Option Chain

When Incyte's strike price is surpassing the current stock price, the option contract against Incyte stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Incyte's option chain is a display of a range of information that helps investors for ways to trade options on Incyte. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Incyte. It also shows strike prices and maturity days for a Incyte against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2024-04-19 CALL at $30.00.97750.003202024-04-1921.6 - 25.60.0In
Call
2024-04-19 CALL at $32.50.90470.006902024-04-1919.1 - 22.30.0In
Call
2024-04-19 CALL at $35.00.94970.006902024-04-1916.7 - 20.90.0In
Call
2024-04-19 CALL at $37.50.94240.008802024-04-1914.6 - 18.00.0In
Call
2024-04-19 CALL at $40.00.93940.011202024-04-1912.3 - 15.20.0In
Call
2024-04-19 CALL at $42.50.95410.012702024-04-199.7 - 12.50.0In
Call
2024-04-19 CALL at $45.00.94380.018802024-04-196.7 - 10.50.0In
Call
2024-04-19 CALL at $47.50.86230.036102024-04-194.7 - 8.10.0In
Call
2024-04-19 CALL at $50.00.93260.053802024-04-191.65 - 5.40.0In
Call
2024-04-19 CALL at $52.50.68190.1681102024-04-191.3 - 1.51.4In
Call
2024-04-19 CALL at $55.00.24310.1471272024-04-190.15 - 0.30.3Out
Call
2024-04-19 CALL at $57.50.05130.0447662024-04-190.0 - 2.150.05Out
Call
2024-04-19 CALL at $62.50.03880.01825102024-04-190.0 - 0.50.07Out
 Put
2024-04-19 PUT at $52.5-0.30210.18231382024-04-190.3 - 0.450.21Out
 Put
2024-04-19 PUT at $55.0-0.81350.15932442024-04-191.6 - 1.851.25In
 Put
2024-04-19 PUT at $57.5-0.85930.06361032024-04-192.2 - 4.32.93In
 Put
2024-04-19 PUT at $60.0-0.74890.03865162024-04-194.9 - 7.76.4In
 Put
2024-04-19 PUT at $62.5-0.73520.0288102024-04-196.9 - 10.77.9In
 Put
2024-04-19 PUT at $65.0-0.76380.024602024-04-199.8 - 13.16.1In
 Put
2024-04-19 PUT at $67.5-0.77250.021302024-04-1911.9 - 15.70.0In
 Put
2024-04-19 PUT at $70.0-0.96680.009802024-04-1915.2 - 18.10.0In
 Put
2024-04-19 PUT at $75.0-0.97150.007202024-04-1919.9 - 23.40.0In
 Put
2024-04-19 PUT at $80.0-0.9480.008602024-04-1925.2 - 28.40.0In
 Put
2024-04-19 PUT at $85.0-0.87930.010902024-04-1929.4 - 32.50.0In
 Put
2024-04-19 PUT at $90.0-0.85020.010402024-04-1934.3 - 38.00.0In

Incyte Total Stockholder Equity Over Time

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
   Total Stockholder Equity   
       Timeline  

Incyte Common Stock Shares Outstanding Over Time

The total number of shares of a company's common stock that are currently owned by all its shareholders.
   Common Stock Shares Outstanding   
       Timeline  

Incyte Total Stockholder Equity

Total Stockholder Equity

5.45 Billion

At this time, Incyte's Total Stockholder Equity is fairly stable compared to the past year.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Incyte without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Analyst Advice Now

   

Analyst Advice

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

Incyte Corporate Directors

Incyte corporate directors refer to members of an Incyte board of directors. The board of directors generally takes responsibility for the Incyte's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Incyte's board members must vote for the resolution. The Incyte board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

Already Invested in Incyte?

The danger of trading Incyte is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Incyte is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Incyte. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Incyte is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Incyte offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Incyte's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Incyte Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Incyte Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.
Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Incyte Stock analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stocks Directory
Find actively traded stocks across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
6.324
Earnings Share
2.65
Revenue Per Share
16.526
Quarterly Revenue Growth
0.093
Return On Assets
0.0646
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.